It	It	B-NP	O	
can	can	B-VP	O	
only	only	I-VP	O	
be	be	I-VP	O	
activated	activate	I-VP	O	
in	in	B-PP	O	
a	a	B-NP	O	
tissue-specific	tissue-specific	I-NP	O	
manner	manner	I-NP	O	
by	by	B-PP	O	
elements	element	B-NP	O	
that	that	B-NP	O	
lie	lie	B-VP	O	
downstream	downstream	B-ADJP	O	
of	of	B-PP	O	
the	the	B-NP	O	
initiation	initiation	I-NP	O	
site	site	I-NP	O	
.	.	O	O	

DNase	DNase	B-NP	O	
I	I	I-NP	O	
and	and	I-NP	O	
gel	gel	I-NP	O	
mobility	mobility	I-NP	O	
shift	shift	I-NP	O	
assays	assay	I-NP	O	
show	show	B-VP	O	
the	the	B-NP	O	
binding	binding	I-NP	O	
of	of	B-PP	O	
a	a	B-NP	O	
number	number	I-NP	O	
of	of	B-PP	O	
nuclear	nuclear	B-NP	O	
factors	factor	I-NP	O	
to	to	B-PP	O	
these	these	B-NP	O	
elements	element	I-NP	O	
,	,	O	O	
including	include	B-PP	O	
Sp1	Sp1	B-NP	O	
and	and	O	O	
CP1	CP1	B-NP	O	
.	.	O	O	

Little	Little	B-NP	O	
is	be	B-VP	O	
known	know	I-VP	O	
of	of	B-PP	O	
expression	expression	B-NP	O	
of	of	B-PP	O	
1,25	1,25	B-NP	O	
-LRB-	(	O	O	
OH	OH	B-NP	O	
-RRB-	)	O	O	
2D3	2D3	B-NP	O	
receptor	receptor	I-NP	O	
RNA	RNA	I-NP	O	
in	in	B-PP	O	
hematopoietic	hematopoietic	B-NP	O	
cells	cell	I-NP	O	
.	.	O	O	

We	We	B-NP	O	
examined	examine	B-VP	O	
the	the	B-NP	O	
expression	expression	B-NP	O	
and	and	O	O	
modulation	modulation	B-NP	O	
of	of	B-PP	O	
expression	expression	B-NP	O	
of	of	B-PP	O	
1,25	1,25	B-NP	O	
-LRB-	(	O	O	
OH	OH	B-NP	O	
-RRB-	)	O	O	
2D3	2D3	B-NP	O	
receptor	receptor	I-NP	O	
RNA	RNA	I-NP	O	
in	in	B-PP	O	
various	various	B-NP	O	
proliferating	proliferate	I-NP	O	
and	and	I-NP	O	
nonproliferating	nonproliferating	I-NP	O	
hematopoietic	hematopoietic	I-NP	O	
cells	cell	I-NP	O	
.	.	O	O	

Immune	Immune	B-NP	O	
response	response	I-NP	O	
of	of	B-PP	O	
peripheral	peripheral	B-NP	O	
blood	blood	I-NP	O	
mononuclear	mononuclear	I-NP	O	
cells	cell	I-NP	O	
to	to	B-PP	O	
HBx-antigen	HBx-antigen	B-NP	O	
of	of	B-PP	O	
hepatitis	hepatitis	B-NP	O	
B	B	I-NP	O	
virus	virus	I-NP	O	
.	.	O	O	

Cloning	Cloning	B-NP	O	
of	of	B-PP	O	
murine	murine	B-NP	O	
TCF-1	TCF-1	I-NP	O	
,	,	O	O	
a	a	B-NP	O	
T	T	I-NP	O	
cell-specific	cell-specific	I-NP	O	
transcription	transcription	I-NP	O	
factor	factor	I-NP	O	
interacting	interact	B-VP	O	
with	with	B-PP	O	
functional	functional	B-NP	O	
motifs	motif	I-NP	O	
in	in	B-PP	O	
the	the	B-NP	O	
CD3-epsilon	CD3-epsilon	I-NP	O	
and	and	I-NP	O	
T	T	I-NP	O	
cell	cell	I-NP	O	
receptor	receptor	I-NP	O	
alpha	alpha	I-NP	O	
enhancers	enhancer	I-NP	O	
.	.	O	O	

The	The	B-NP	O	
T	T	I-NP	O	
lineage-specific	lineage-specific	I-NP	O	
expression	expression	I-NP	O	
and	and	O	O	
the	the	B-NP	O	
affinity	affinity	I-NP	O	
for	for	B-PP	O	
functional	functional	B-NP	O	
motifs	motif	I-NP	O	
in	in	B-PP	O	
the	the	O	O	
TCR-alpha	TCR-alpha	B-NP	O	
and	and	O	O	
CD3-epsilon	CD3-epsilon	B-NP	O	
enhancers	enhancer	B-NP	O	
imply	imply	B-VP	B-SPECCUE	
an	an	B-NP	O	
important	important	I-NP	O	
role	role	I-NP	O	
for	for	B-PP	O	
TCF-1	TCF-1	B-NP	O	
in	in	B-PP	O	
the	the	B-NP	O	
establishment	establishment	I-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
mature	mature	I-NP	O	
T	T	I-NP	O	
cell	cell	I-NP	O	
phenotype	phenotype	I-NP	O	
.	.	O	O	

CD3-epsilon	CD3-epsilon	B-NP	O	
gene	gene	I-NP	O	
expression	expression	I-NP	O	
is	be	B-VP	O	
confined	confine	I-VP	O	
to	to	B-PP	O	
the	the	B-NP	O	
T	T	I-NP	O	
cell	cell	I-NP	O	
lineage	lineage	I-NP	O	
.	.	O	O	

Finally	Finally	B-ADVP	O	
we	we	B-NP	O	
explored	explore	B-VP	O	
the	the	B-NP	O	
possible	possible	I-NP	B-SPECCUE	
role	role	I-NP	O	
of	of	B-PP	O	
5-hydroxyeicosatetraenoic	5-hydroxyeicosatetraenoic	B-NP	O	
acid	acid	I-NP	O	
as	as	B-PP	O	
a	a	B-NP	O	
regulator	regulator	I-NP	O	
of	of	B-PP	O	
arachidonic	arachidonic	B-NP	O	
acid	acid	I-NP	O	
liberation	liberation	I-NP	O	
demonstrating	demonstrate	B-VP	O	
that	that	B-SBAR	O	
endogenous	endogenous	B-NP	O	
5-lipoxygenase	5-lipoxygenase	I-NP	O	
activity	activity	I-NP	O	
modulates	modulate	B-VP	O	
platelet-activating	platelet-activating	B-NP	O	
factor	factor	I-NP	O	
induced	induced	B-NP	O	
arachidonic	arachidonic	I-NP	O	
acid	acid	I-NP	O	
release	release	I-NP	O	
perhaps	perhaps	B-ADVP	B-SPECCUE	
acting	act	B-VP	O	
at	at	B-PP	O	
the	the	B-NP	O	
level	level	I-NP	O	
of	of	B-PP	O	
phospholipase	phospholipase	B-NP	O	
A2	A2	I-NP	O	
.	.	O	O	

Platelet-activating	Platelet-activating	B-NP	O	
factor	factor	I-NP	O	
is	be	B-VP	O	
a	a	B-NP	O	
potent	potent	I-NP	O	
mediator	mediator	I-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
inflammatory	inflammatory	I-NP	O	
response	response	I-NP	O	
.	.	O	O	

However	However	B-ADVP	O	
,	,	O	O	
combination	combination	B-NP	O	
of	of	B-PP	O	
OKT3	OKT3	B-NP	O	
and	and	O	O	
phorbol	phorbol	B-NP	O	
myristate	myristate	I-NP	O	
acetate	acetate	I-NP	O	
produced	produce	B-VP	O	
a	a	B-NP	O	
concentration	concentration	I-NP	O	
of	of	B-PP	O	
binding	bind	B-NP	O	
sites	site	I-NP	O	
similar	similar	B-ADJP	O	
to	to	B-PP	O	
the	the	B-NP	O	
PHA-activated	PHA-activated	I-NP	O	
cells	cell	I-NP	O	
.	.	O	O	

The	The	B-NP	O	
receptor	receptor	I-NP	O	
from	from	B-PP	O	
OKT3	OKT3	B-NP	O	
and	and	I-NP	O	
OKT3	OKT3	I-NP	O	
+	+	O	O	
phorbol	phorbol	B-NP	O	
myristate	myristate	I-NP	O	
acetate-activated	acetate-activated	B-VP	O	
lymphocytes	lymphocyte	B-NP	O	
exhibited	exhibit	B-VP	O	
decreased	decrease	B-NP	O	
binding	binding	I-NP	O	
to	to	B-PP	O	
DNA-cellulose	DNA-cellulose	B-NP	O	
compared	compare	B-VP	O	
to	to	B-PP	O	
PHA-activated	PHA-activated	B-NP	O	
lymphocytes	lymphocyte	I-NP	O	
.	.	O	O	

In	In	B-PP	O	
lymphocytes	lymphocyte	B-NP	O	
activated	activate	B-VP	O	
either	either	B-PP	O	
by	by	I-PP	O	
PHA	PHA	B-NP	O	
or	or	O	O	
OKT3	OKT3	B-NP	O	
-LRB-	(	B-PP	O	
but	but	I-PP	O	
not	not	B-PP	O	
in	in	I-PP	O	
resting	rest	B-NP	O	
cells	cell	I-NP	O	
-RRB-	)	O	O	
,	,	O	O	
a	a	B-NP	O	
50-kDa	50-kDa	I-NP	O	
species	specie	I-NP	O	
cross-reacting	cross-reacte	B-VP	O	
with	with	B-PP	O	
a	a	B-NP	O	
monoclonal	monoclonal	I-NP	O	
antibody	antibody	I-NP	O	
against	against	B-PP	O	
the	the	B-NP	O	
intestinal	intestinal	I-NP	O	
vitamin	vitamin	I-NP	O	
D	D	I-NP	O	
receptor	receptor	I-NP	O	
was	be	B-VP	O	
detected	detect	I-VP	O	
.	.	O	O	

These	These	B-NP	O	
studies	study	I-NP	O	
have	have	B-VP	O	
been	be	I-VP	O	
extended	extend	I-VP	O	
to	to	I-VP	O	
show	show	I-VP	O	
that	that	B-SBAR	O	
-LRB-	(	B-LST	O	
i	i	I-LST	O	
-RRB-	)	O	O	
a	a	B-NP	O	
mutant	mutant	I-NP	O	
EBV	EBV	I-NP	O	
strain	strain	I-NP	O	
lacking	lack	B-VP	O	
the	the	B-NP	O	
gene	gene	I-NP	O	
encoding	encode	B-VP	O	
EBNA	EBNA	B-NP	O	
2	2	I-NP	O	
fails	fail	B-VP	O	
to	to	I-VP	O	
switch	switch	I-VP	O	
from	from	B-PP	O	
Wp	Wp	B-NP	O	
to	to	B-PP	O	
Cp	Cp	B-NP	O	
usage	usage	I-NP	O	
in	in	B-PP	O	
primary	primary	B-NP	O	
B	B	I-NP	O	
lymphocytes	lymphocyte	I-NP	O	
,	,	O	O	
although	although	B-SBAR	O	
the	the	B-NP	O	
virus	virus	I-NP	O	
contains	contain	B-VP	O	
a	a	B-NP	O	
functional	functional	I-NP	O	
Cp	Cp	I-NP	O	
;	;	O	O	
-LRB-	(	B-LST	O	
ii	ii	I-LST	O	
-RRB-	)	O	O	
a	a	B-NP	O	
region	region	I-NP	O	
from	from	B-PP	O	
-429	-429	B-NP	O	
to	to	I-NP	O	
-245	-245	I-NP	O	
base	base	I-NP	O	
pairs	pair	I-NP	O	
upstream	upstream	B-ADJP	O	
of	of	B-PP	O	
Cp	Cp	B-NP	O	
is	be	B-VP	O	
essential	essential	B-ADJP	O	
for	for	B-PP	O	
Cp	Cp	B-NP	O	
activity	activity	I-NP	O	
in	in	B-PP	O	
B	B	B-NP	O	
lymphocytes	lymphocyte	I-NP	O	
,	,	O	O	
but	but	O	O	
only	only	B-PP	O	
in	in	I-PP	O	
the	the	B-NP	O	
context	context	I-NP	O	
of	of	B-PP	O	
upstream	upstream	B-NP	O	
and	and	I-NP	O	
downstream	downstream	I-NP	O	
sequences	sequence	I-NP	O	
;	;	O	O	
-LRB-	(	B-LST	O	
iii	iii	I-LST	O	
-RRB-	)	O	O	
this	this	B-NP	O	
region	region	I-NP	O	
contains	contain	B-VP	O	
an	an	B-NP	O	
EBNA	EBNA	I-NP	O	
2-dependent	2-dependent	I-NP	O	
enhancer	enhancer	I-NP	O	
;	;	O	O	
and	and	O	O	
-LRB-	(	B-LST	O	
iv	iv	I-LST	O	
-RRB-	)	O	O	
DNase	DNase	B-NP	O	
I	I	I-NP	O	
protection	protection	I-NP	O	
employing	employ	B-VP	O	
nuclear	nuclear	B-NP	O	
extracts	extract	I-NP	O	
from	from	B-PP	O	
B	B	B-NP	O	
and	and	O	O	
T	T	B-NP	O	
lymphocytes	lymphocyte	B-NP	O	
revealed	reveal	B-VP	O	
a	a	B-NP	O	
B-cell-specific	B-cell-specific	I-NP	O	
footprint	footprint	I-NP	O	
in	in	B-PP	O	
the	the	B-NP	O	
region	region	I-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
EBNA	EBNA	I-NP	O	
2-dependent	2-dependent	I-NP	O	
enhancer	enhancer	I-NP	O	
.	.	O	O	

Similar	Similar	B-ADJP	O	
to	to	B-PP	O	
its	its	B-NP	O	
effect	effect	I-NP	O	
on	on	B-PP	O	
the	the	B-NP	O	
induction	induction	I-NP	O	
of	of	B-PP	O	
AP1	AP1	B-NP	O	
by	by	B-PP	O	
okadaic	okadaic	B-NP	O	
acid	acid	I-NP	O	
,	,	O	O	
PMA	PMA	B-NP	O	
inhibits	inhibit	B-VP	O	
the	the	B-NP	O	
induction	induction	I-NP	O	
of	of	B-PP	O	
c-jun	c-jun	B-NP	O	
mRNA	mRNA	I-NP	O	
by	by	B-PP	O	
okadaic	okadaic	B-NP	O	
acid	acid	I-NP	O	
.	.	O	O	

In	In	B-PP	O	
patients	patient	B-NP	O	
suffering	suffer	B-VP	O	
from	from	B-PP	O	
Cushing	Cushing	B-NP	O	
's	's	B-NP	O	
syndrome	syndrome	I-NP	O	
,	,	O	O	
the	the	B-NP	O	
circadian	circadian	I-NP	O	
rhythm	rhythm	I-NP	O	
of	of	B-PP	O	
plasma	plasma	B-NP	O	
cortisol	cortisol	I-NP	O	
either	either	O	B-SPECCUE	
disappeared	disappear	B-VP	O	
or	or	O	B-SPECCUE	
was	be	B-VP	O	
inverted	invert	I-VP	O	
while	while	B-SBAR	O	
that	that	B-NP	O	
of	of	B-PP	O	
GR	GR	B-NP	O	
did	do	B-VP	O	
not	not	I-VP	O	
significantly	significantly	I-VP	O	
deviate	deviate	I-VP	O	
from	from	B-PP	O	
the	the	B-NP	O	
normal	normal	I-NP	O	
subjects	subject	I-NP	O	
.	.	O	O	

Conversely	Conversely	B-ADVP	O	
,	,	O	O	
diurnal	diurnal	B-NP	O	
rhythmicity	rhythmicity	I-NP	O	
persisted	persist	B-VP	O	
in	in	B-PP	O	
apoplexy	apoplexy	B-NP	O	
patients	patient	I-NP	O	
whose	whose	B-NP	O	
lesions	lesion	I-NP	O	
were	be	B-VP	O	
in	in	B-PP	O	
the	the	B-NP	O	
cerebral	cerebral	I-NP	O	
cortex	cortex	I-NP	O	
.	.	O	O	

A	A	B-NP	O	
less	less	I-NP	O	
pronounced	pronounced	I-NP	O	
reduction	reduction	I-NP	O	
in	in	B-PP	O	
lambda	lambda	B-NP	O	
L	L	I-NP	O	
chain	chain	I-NP	O	
and	and	O	O	
microH	microH	B-NP	O	
chain	chain	I-NP	O	
was	be	B-VP	O	
also	also	I-VP	O	
noted	note	I-VP	O	
.	.	O	O	

The	The	B-NP	O	
rate	rate	I-NP	O	
of	of	B-PP	O	
transcription	transcription	B-NP	O	
initiation	initiation	I-NP	O	
directed	direct	B-VP	O	
by	by	B-PP	O	
the	the	B-NP	O	
long	long	I-NP	O	
terminal	terminal	I-NP	O	
repeat	repeat	I-NP	O	
-LRB-	(	O	O	
LTR	LTR	B-NP	O	
-RRB-	)	O	O	
of	of	B-PP	O	
HIV-1	HIV-1	B-NP	O	
increases	increase	I-NP	O	
in	in	B-PP	O	
response	response	I-PP	O	
to	to	I-PP	O	
mitogenic	mitogenic	B-NP	O	
stimuli	stimulus	I-NP	O	
of	of	B-PP	O	
T	T	B-NP	O	
cells	cell	I-NP	O	
.	.	O	O	

The	The	B-NP	O	
HIV-1	HIV-1	I-NP	O	
mutant	mutant	I-NP	O	
virus	virus	I-NP	O	
containing	contain	B-VP	O	
both	both	O	O	
NF	NF	B-NP	O	
kappa	kappa	I-NP	O	
B	B	I-NP	O	
and	and	O	O	
NFAT-1	NFAT-1	B-NP	O	
deletion	deletion	B-NP	O	
was	be	B-VP	O	
able	able	B-ADJP	O	
to	to	B-VP	O	
replicate	replicate	I-VP	O	
although	although	B-SBAR	O	
at	at	B-PP	O	
a	a	B-NP	O	
much	much	I-NP	O	
decreased	decrease	I-NP	O	
growth	growth	I-NP	O	
rate	rate	I-NP	O	
,	,	O	O	
while	while	B-SBAR	O	
the	the	B-NP	O	
deletion	deletion	I-NP	O	
of	of	B-PP	O	
NFAT-1	NFAT-1	B-NP	O	
alone	alone	B-ADVP	O	
increased	increase	B-VP	O	
the	the	B-NP	O	
viral	viral	I-NP	O	
growth	growth	I-NP	O	
rate	rate	I-NP	O	
in	in	B-PP	O	
Jurkat	Jurkat	B-NP	O	
cells	cell	I-NP	O	
.	.	O	O	

We	We	B-NP	O	
report	report	B-VP	O	
the	the	B-NP	O	
identification	identification	I-NP	O	
of	of	B-PP	O	
a	a	B-NP	O	
T	T	I-NP	O	
cell-specific	cell-specific	I-NP	O	
transcription	transcription	I-NP	O	
factor	factor	I-NP	O	
,	,	O	O	
TCF-1	TCF-1	B-NP	O	
,	,	O	O	
binding	bind	B-VP	O	
to	to	B-PP	O	
this	this	B-NP	O	
element	element	I-NP	O	
.	.	O	O	

Activation	Activation	B-NP	O	
of	of	B-PP	O	
T	T	B-NP	O	
lymphocytes	lymphocyte	I-NP	O	
induces	induce	B-VP	O	
an	an	B-NP	O	
NF-kappa	NF-kappa	I-NP	O	
B-like	B-like	I-NP	O	
binding	binding	I-NP	O	
activity	activity	I-NP	O	
to	to	B-PP	O	
the	the	B-NP	O	
B2	B2	I-NP	O	
site	site	I-NP	O	
,	,	O	O	
concomitant	concomitant	B-ADJP	O	
with	with	B-PP	O	
activation	activation	B-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
proenkephalin	proenkephalin	I-NP	O	
promoter	promoter	I-NP	O	
.	.	O	O	

Mutations	Mutation	B-NP	O	
at	at	B-PP	O	
the	the	B-NP	O	
B2	B2	I-NP	O	
site	site	I-NP	O	
abolish	abolish	B-VP	O	
this	this	B-NP	O	
transcriptional	transcriptional	I-NP	O	
activation	activation	I-NP	O	
.	.	O	O	

Thus	Thus	B-ADVP	O	
,	,	O	O	
it	it	B-NP	O	
appears	appear	B-VP	B-SPECCUE	
that	that	B-SBAR	O	
the	the	B-NP	O	
T-cell-specific	T-cell-specific	I-NP	O	
activation	activation	I-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
proenkephalin	proenkephalin	I-NP	O	
promoter	promoter	I-NP	O	
is	be	B-VP	O	
mediated	mediate	I-VP	O	
by	by	B-PP	O	
NF-kappa	NF-kappa	B-NP	O	
B	B	I-NP	O	
.	.	O	O	

The	The	B-NP	O	
IL-2	IL-2	I-NP	O	
and	and	O	O	
the	the	B-NP	O	
IL-2-R	IL-2-R	I-NP	O	
alpha	alpha	I-NP	O	
genes	gene	B-NP	O	
are	be	B-VP	O	
both	both	O	O	
expressed	express	B-VP	O	
transiently	transiently	B-ADVP	O	
in	in	B-PP	O	
normal	normal	B-NP	O	
T	T	I-NP	O	
lymphocytes	lymphocyte	I-NP	O	
after	after	B-PP	O	
Ag	Ag	B-NP	O	
or	or	O	O	
mitogen	mitogen	B-NP	O	
activation	activation	I-NP	O	
.	.	O	O	

Isolation	Isolation	B-NP	O	
of	of	B-PP	O	
a	a	B-NP	O	
rel-related	rel-related	I-NP	O	
human	human	I-NP	O	
cDNA	cDNA	I-NP	O	
that	that	B-NP	O	
potentially	potentially	B-ADVP	B-SPECCUE	
encodes	encode	B-VP	O	
the	the	B-NP	O	
65-kD	65-kD	I-NP	O	
subunit	subunit	I-NP	O	
of	of	B-PP	O	
NF-kappa	NF-kappa	B-NP	O	
B	B	I-NP	O	
-LRB-	[	O	O	
published	publish	B-NP	O	
erratum	erratum	I-NP	O	
appears	appear	B-VP	O	
in	in	B-PP	O	
Science	Science	B-NP	O	
1991	1991	I-NP	O	
Oct	Oct	I-NP	O	
4	4	I-NP	O	
;	;	O	O	
254	254	B-NP	O	
-LRB-	(	O	O	
5028	5028	B-NP	O	
-RRB-	)	O	O	
:	:	O	O	
11	11	B-NP	O	
-RRB-	]	O	O	

The	The	B-NP	O	
present	present	I-NP	O	
data	datum	I-NP	O	
,	,	O	O	
along	along	B-ADVP	O	
with	with	B-PP	O	
other	other	B-NP	O	
findings	finding	I-NP	O	
of	of	B-PP	O	
HPA	HPA	B-NP	O	
abnormalities	abnormality	I-NP	O	
in	in	B-PP	O	
PTSD	PTSD	B-NP	O	
,	,	O	O	
support	support	B-VP	O	
the	the	B-NP	O	
possibility	possibility	I-NP	B-SPECCUE	
of	of	B-PP	O	
a	a	B-NP	O	
greater	great	I-NP	O	
negative	negative	I-NP	O	
feedback	feedback	I-NP	O	
sensitivity	sensitivity	I-NP	O	
at	at	B-PP	O	
one	one	B-NP	O	
or	or	I-NP	O	
more	more	I-NP	O	
levels	level	I-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
HPA	HPA	I-NP	O	
axis	axis	I-NP	O	
.	.	O	O	

Using	Use	B-VP	O	
amino	amino	B-NP	O	
acid	acid	I-NP	O	
sequence	sequence	I-NP	O	
information	information	I-NP	O	
derived	derive	B-VP	O	
from	from	B-PP	O	
the	the	B-NP	O	
DNA	DNA	I-NP	O	
affinity-purified	affinity-purified	I-NP	O	
protein	protein	I-NP	O	
,	,	O	O	
we	we	B-NP	O	
have	have	B-VP	O	
now	now	I-VP	O	
isolated	isolate	I-VP	O	
cDNA	cDNA	B-NP	O	
clones	clone	I-NP	O	
encoding	encode	B-VP	O	
TCF-1	TCF-1	B-NP	O	
alpha	alpha	I-NP	O	
.	.	O	O	

Multiple	Multiple	B-NP	O	
Oct2	Oct2	I-NP	O	
isoforms	isoform	I-NP	O	
are	be	B-VP	O	
generated	generate	I-VP	O	
by	by	B-PP	O	
alternative	alternative	B-NP	O	
splicing	splicing	I-NP	O	
.	.	O	O	

In	In	B-PP	O	
cotransfection	cotransfection	B-NP	O	
experiments	experiment	I-NP	O	
we	we	B-NP	O	
show	show	B-VP	O	
that	that	B-SBAR	O	
all	all	B-NP	O	
the	the	I-NP	O	
isoforms	isoform	I-NP	O	
are	be	B-VP	O	
able	able	B-ADJP	O	
to	to	B-VP	O	
activate	activate	I-VP	O	
an	an	B-NP	O	
octamer	octamer	I-NP	O	
containing	contain	B-VP	O	
promoter	promoter	B-NP	O	
element	element	I-NP	O	
in	in	B-PP	O	
fibroblasts	fibroblast	B-NP	O	
revealing	reveal	B-VP	O	
an	an	B-NP	O	
unexpected	unexpected	I-NP	O	
functional	functional	I-NP	O	
redundancy	redundancy	I-NP	O	
.	.	O	O	

Analysis	Analysis	B-NP	O	
of	of	B-PP	O	
human	human	B-NP	O	
and	and	I-NP	O	
murine	murine	I-NP	O	
GATA-3	GATA-3	I-NP	O	
factors	factor	I-NP	O	
shows	show	B-VP	O	
a	a	B-NP	O	
striking	striking	I-NP	O	
degree	degree	I-NP	O	
of	of	B-PP	O	
amino	amino	B-NP	O	
acid	acid	I-NP	O	
sequence	sequence	I-NP	O	
identity	identity	I-NP	O	
and	and	O	O	
similar	similar	B-NP	O	
patterns	pattern	I-NP	O	
of	of	B-PP	O	
tissue	tissue	B-NP	O	
specificity	specificity	I-NP	O	
of	of	B-PP	O	
expression	expression	B-NP	O	
in	in	B-PP	O	
these	these	B-NP	O	
three	three	I-NP	O	
organisms	organism	I-NP	O	
.	.	O	O	

It	It	B-NP	O	
is	be	B-VP	O	
located	locate	I-VP	O	
in	in	B-PP	O	
the	the	B-NP	O	
nucleus	nucleus	I-NP	O	
in	in	B-PP	O	
mature	mature	B-NP	O	
B	B	I-NP	O	
cells	cell	I-NP	O	
,	,	O	O	
but	but	O	O	
is	be	B-VP	O	
present	present	B-ADJP	O	
in	in	B-PP	O	
other	other	B-NP	O	
cell	cell	I-NP	O	
types	type	I-NP	O	
as	as	B-PP	O	
an	an	B-NP	O	
inactive	inactive	I-NP	O	
cytoplasmic	cytoplasmic	I-NP	O	
complex	complex	I-NP	O	
.	.	O	O	

HIV	HIV	B-NP	O	
enhancer	enhancer	I-NP	O	
activity	activity	I-NP	O	
perpetuated	perpetuate	B-VP	O	
by	by	B-PP	O	
NF-kappa	NF-kappa	B-NP	O	
B	B	I-NP	O	
induction	induction	I-NP	O	
on	on	B-PP	O	
infection	infection	B-NP	O	
of	of	B-PP	O	
monocytes	monocyte	B-NP	O	
-LRB-	[	O	O	
see	see	B-VP	O	
comments	comment	B-NP	O	
-RRB-	]	O	O	

In	In	B-PP	O	
contrast	contrast	B-NP	O	
,	,	O	O	
fixed	fixed	B-NP	O	
tissue	tissue	I-NP	O	
macrophages	macrophage	I-NP	O	
express	express	B-VP	O	
detectable	detectable	B-NP	O	
HIV	HIV	I-NP	O	
proteins	protein	I-NP	O	
,	,	O	O	
indicating	indicate	B-VP	O	
permanent	permanent	B-NP	O	
virus	virus	I-NP	O	
transcription	transcription	I-NP	O	
.	.	O	O	

The	The	B-NP	O	
dexamethasone	dexamethasone	I-NP	O	
Kd	Kd	I-NP	O	
was	be	B-VP	O	
2.45	2.45	B-NP	O	
±	±	O	O	
0.58	0.58	B-NP	O	
nM	nM	I-NP	O	
-LRB-	(	O	O	
mean	mean	B-NP	O	
±	±	I-NP	O	
SEM	SEM	I-NP	O	
,	,	O	O	
n	n	B-NP	O	
=	=	B-VP	O	
6	6	B-NP	O	
-RRB-	)	O	O	
in	in	B-PP	O	
the	the	O	O	
CS	CS	B-NP	O	
group	group	B-NP	O	
and	and	O	O	
1.6	1.6	B-NP	O	
±	±	I-NP	O	
0.35	0.35	I-NP	O	
nM	nM	I-NP	O	
-LRB-	(	O	O	
mean	mean	B-NP	O	
±	±	I-NP	O	
SEM	SEM	I-NP	O	
,	,	O	O	
n	n	B-NP	O	
=	=	B-VP	O	
6	6	B-NP	O	
-RRB-	)	O	O	
in	in	B-PP	O	
the	the	B-NP	O	
CR	CR	I-NP	O	
group	group	I-NP	O	
of	of	B-PP	O	
patients	patient	B-NP	O	
-LRB-	(	O	O	
p	p	B-NP	O	
=	=	B-VP	O	
0.14	0.14	B-NP	O	
-RRB-	)	O	O	
.	.	O	O	

Finally	Finally	B-ADVP	O	
,	,	O	O	
two	two	B-NP	O	
other	other	I-NP	O	
domains	domain	I-NP	O	
,	,	O	O	
located	located	B-ADJP	O	
at	at	B-PP	O	
positions	position	B-NP	O	
-460	-460	B-NP	O	
and	and	O	O	
-510	-510	B-NP	O	
,	,	O	O	
interact	interact	B-VP	O	
with	with	B-PP	O	
proteins	protein	B-NP	O	
that	that	B-NP	O	
are	be	B-VP	O	
only	only	B-ADJP	O	
present	present	I-ADJP	O	
in	in	B-PP	O	
megakaryocytic	megakaryocytic	B-NP	O	
cells	cell	I-NP	O	
.	.	O	O	

Recent	Recent	B-NP	O	
development	development	I-NP	O	
of	of	B-PP	O	
primary	primary	B-NP	O	
cultures	culture	I-NP	O	
of	of	B-PP	O	
human	human	B-NP	O	
megakaryocytes	megakaryocyte	I-NP	O	
and	and	O	O	
the	the	B-NP	O	
molecular	molecular	I-NP	O	
cloning	cloning	I-NP	O	
of	of	B-PP	O	
genes	gene	B-NP	O	
that	that	B-NP	O	
are	be	B-VP	O	
specific	specific	B-ADJP	O	
to	to	B-PP	O	
this	this	B-NP	O	
lineage	lineage	I-NP	O	
offer	offer	B-VP	O	
the	the	B-NP	O	
possibility	possibility	I-NP	O	
of	of	B-PP	O	
getting	get	B-VP	O	
some	some	B-NP	O	
insights	insight	I-NP	O	
into	into	B-PP	O	
the	the	B-NP	O	
genetic	genetic	I-NP	O	
mechanisms	mechanism	I-NP	O	
that	that	B-NP	O	
control	control	B-VP	O	
megakaryocytopoiesis	megakaryocytopoiesis	B-NP	O	
.	.	O	O	

For	For	B-PP	O	
these	these	B-NP	O	
reasons	reason	I-NP	O	
,	,	O	O	
the	the	B-NP	O	
5'-flanking	5'-flanking	I-NP	O	
region	region	I-NP	O	
of	of	B-PP	O	
the	the	B-NP	O	
GPIIb	GPIIb	I-NP	O	
gene	gene	I-NP	O	
was	be	B-VP	O	
used	use	I-VP	O	
to	to	B-VP	O	
identify	identify	I-VP	O	
the	the	B-NP	O	
regions	region	I-NP	O	
that	that	B-NP	O	
interact	interact	B-VP	O	
with	with	B-PP	O	
DNA-binding	DNA-binding	B-NP	O	
nuclear	nuclear	I-NP	O	
factors	factor	I-NP	O	
.	.	O	O	

Within	Within	B-PP	O	
this	this	B-NP	O	
region	region	I-NP	O	
,	,	O	O	
we	we	B-NP	O	
have	have	B-VP	O	
identified	identify	I-VP	O	
several	several	B-NP	O	
sequences	sequence	I-NP	O	
that	that	B-NP	O	
are	be	B-VP	O	
implicated	implicate	I-VP	O	
in	in	B-PP	O	
DNA	DNA	B-NP	O	
protein	protein	I-NP	O	
interactions	interaction	I-NP	O	
as	as	B-SBAR	O	
shown	show	B-VP	O	
in	in	B-PP	O	
DNAse	DNAse	B-NP	O	
I	I	I-NP	O	
footprints	footprint	I-NP	O	
and	and	O	O	
gel	gel	B-NP	O	
mobility	mobility	I-NP	O	
shift	shift	I-NP	O	
assays	assay	I-NP	O	
.	.	O	O	

With	With	B-PP	O	
the	the	B-NP	O	
antibodies	antibody	I-NP	O	
Ki-67	Ki-67	I-NP	O	
and	and	O	O	
anti-p-145	anti-p-145	B-NP	O	
an	an	B-NP	O	
increased	increase	I-NP	O	
rate	rate	I-NP	O	
of	of	B-PP	O	
nuclear	nuclear	B-NP	O	
and	and	I-NP	O	
nucleolar	nucleolar	I-NP	O	
staining	staining	I-NP	O	
resulted	result	B-VP	O	
in	in	B-PP	O	
cells	cell	B-NP	O	
from	from	B-PP	O	
highly	highly	B-NP	O	
malignant	malignant	I-NP	O	
lymphomas	lymphoma	I-NP	O	
.	.	O	O	
